MGFRX
Price
$9.50
Change
-$0.05 (-0.52%)
Updated
Aug 11 closing price
Net Assets
163.34M
RPEBX
Price
$68.52
Change
-$0.19 (-0.28%)
Updated
Aug 11 closing price
Net Assets
157.43B
Interact to see
Advertisement

MGFRX vs RPEBX

Header iconMGFRX vs RPEBX Comparison
Open Charts MGFRX vs RPEBXBanner chart's image
MassMutual Global R4
Price$9.50
Change-$0.05 (-0.52%)
VolumeN/A
Net Assets163.34M
American Funds New Perspective R2E
Price$68.52
Change-$0.19 (-0.28%)
VolumeN/A
Net Assets157.43B
MGFRX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MGFRX vs. RPEBX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGFRX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 157B vs. MGFRX (163M). RPEBX pays higher dividends than MGFRX: RPEBX (0.12) vs MGFRX (0.00). MGFRX was incepted earlier than RPEBX: MGFRX (11 years) vs RPEBX (11 years). MGFRX (1.38) is less costly to investors than RPEBX (1.21). RPEBX is a more actively managed with annual turnover of: 24.00 vs. MGFRX (6.00). MGFRX has a lower initial minimum investment than RPEBX: MGFRX (0) vs RPEBX (250). RPEBX annual gain was more profitable for investors over the last year : 15.32 vs. MGFRX (-2.45). RPEBX return over 5 years is better than : 33.41 vs. MGFRX (-33.36).
MGFRXRPEBXMGFRX / RPEBX
Total Expense Ratio1.381.21114%
Annual Report Gross Expense Ratio1.381.21114%
Fund Existence11 years11 years-
Gain YTD7.91013.50059%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets163M157B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year-2.4515.32-16%
Returns for 3 years-25.8531.18-83%
Returns for 5 years-33.3633.41-100%
Returns for 10 years-36.1178.61-46%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCSAX16.63N/A
N/A
Allspring Common Stock A
THCGX29.87N/A
N/A
Thornburg Small/Mid Cap Growth A
CDCRX11.66N/A
N/A
Copeland Dividend Growth Fund Class C
JHURX34.58N/A
N/A
JPMorgan Emerging Markets Equity R3
WOFRX64.21N/A
N/A
Allspring Opportunity R6